Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 4 (2007), Issue 11 (November)

1. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
   N Engl J Med, 357(19): 1916-27. [Abstract] [Full-text]
2. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
   Int J Lab Hematol, 29(6): 461-3. [Abstract] [Full-text]
3. IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
   Bone Marrow Transplant, 40(11): 1019-25. [Abstract] [Full-text]
4. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
   Am J Clin Pathol, 128(6): 958-65. [Abstract] [Full-text]
5. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.
   J Clin Pathol, 60(12): 1342-9. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.